Devens, MA – Colliers announced that its client, Watson-Marlow Fluid Technology Group , headquartered in the UK, will hold official groundbreaking event for its new site at Redtail Heights, Devens on Thursday, November 18.
The commemorative event shortly follows Watson-Marlow’s recent announcement of signing a lease for a new manufacturing facility in Devens, Massachusetts, which will expand their U.S. footprint in the Northeast.
Located at Red Tail Heights, 16 Bulge Road, the 150,000-square-foot build-to-suit project for Watson-Marlow will feature eight ISO14644-1 Class 7 cleanrooms, warehousing, and offices, with space for two further cleanrooms within the initial footprint. As one of only a few remaining shovel-ready opportunities in the Devens business park, the 25.4-acre site at 16 Bulge Road recently sold from MassDevelopment to Indianapolis-based Scannell Properties who has hired ARCO National Construction to commence the project in Q4 2021 with planned completion for late 2022. Colliers’ Senior Vice President Jake Borden along with Executive Vice President Greg Klemmer led the site selection process and subsequent lease negotiations on behalf of Watson-Marlow.“It was our privilege to represent the Watson-Marlow team through their comprehensive search for a new facility here in Massachusetts. Devens, with its rapidly growing life science and GMP manufacturing cluster, combines convenient Route 2 proximity with immediate access to major life science employers and talent that will be accretive to Watson-Marlow’s core business. We are excited to see the facility take shape in the coming year,” said Jake Borden, Senior Vice President, Colliers Part of Spirax-Sarco Engineering plc, a FTSE100 Company, Watson-Marlow specializes in high-quality fluid manufacturing solutions for the life sciences and process industries. This significant investment in the expansion of its manufacturing capacity will support Watson-Marlow’s future growth in the Americas. “The new US facility is an important milestone in the Watson-Marlow company history and marks a significant commitment to serving our customers in the Americas region. This exciting development is bringing us closer to our customers whose purpose is to help the world around us, from advancing cell and gene therapies through to ensuring people have access to clean drinking water. Together we will continue to develop market-leading fluid management solutions to engineer a more sustainable future.” – Andrew Mines, Managing Director, Watson-Marlow The development of the facility will bring over 150 job opportunities to the local area. Production will replicate Watson-Marlow’s European facilities, ensuring continued product quality for customers, by using the same raw materials, components, processes and work instructions. With construction expected to finish in late 2022, the first products are due to be shipped in late Q4 2022.